Biohaven Pharmaceuticals pays $2.35M for another downtown New Haven property
Google
Biohaven Pharmaceutical's New Haven headquarters, at 215 Church St., at left, and its new property, at 209 Church St., at right,
Biohaven Pharmaceuticals Inc. has purchased another downtown New Haven property next to its main headquarters as it continues expanding throughout the Elm City.
The New Haven-based drug company bought 209 Church St., for $2.35 million from Church 209 LLC in a deal recorded May 8. Church 209 bought the property for $1.7 million in 2020, according to city records.
The former bank building features 8,900 square feet and was built in 1929.
Biohaven officials did not immediately respond to a request for comment Friday morning on the company’s plans for the new Church Street property, but previous reports stated Biohaven is looking to create a New Haven campus-type presence.
In early 2022, Biohaven bought the 42,000-square-foot former landmark Quinnipiack Club at Church and Orange streets for $4.1 million
Biohaven is based nearby at 215 Church St., and has developed major market drugs such as migraine drug Nurtec ODT, and has been pursuing treatments for neurological and psychiatric diseases including Alzheimer’s, obsessive compulsive disorder and amyotrophic lateral sclerosis (ALS).
Most Recent
Most Recent
0 Comments